News Roundup: August 7 to August 13
Your weekly roundup of the latest news from Drug Topics®.
Fallopian Tube Removal Not Associated With Ovarian Cancer Risk
A substantial collection of evidence indicates that the fallopian tube serves as the primary site of origin for a large portion of high-grade serous ovarian cancers.
Upcoming DIR Fee Changes Still Causing Concern for Pharmacists
New DIR fee rules eliminate clawbacks, but may create cashflow challenges for pharmacies in the first half of 2024.
ADHD Medication Shortages Raise Concerns Among Young Patients and Their Families
According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023.
Blood Pressure Can Predict Adverse Pregnancy Outcomes
Results from a recent study indicated that lowering the threshold for abnormal blood pressure in the second half of pregnancy from 140/90 mm Hg would not increase accuracy in identifying maternal or perinatal risk in patients.
High BMI in Breast Cancer Patients Linked With Increased Cardiotoxicity During Chemotherapy
A recent study being presented at the American College of Cardiology Latin America 2023 conference found the prevalence of cardiotoxicity among patients with breast cancer undergoing chemotherapy was 11.94%.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
